Verily Forms Strategic Alliances with Novartis, Otsuka, Pfizer and Sanofi to Transform Clinical Research

Leading biopharmaceutical organizations join Project Baseline initiative to engage more patients and clinicians in research and speed evidence generation Verily, an Alphabet company, today announced strategic alliances with Novartis, Otsuka, Pfizer Inc. and Sanofi to develop digitally innovative, patient-centered clinical research programs using Project Baseline’s evidence generation platform and tools. The Baseline Platform is designed

Read More


Bioprinting in regenerative medicine

In the paper “Three‐Dimensional Bioprinting in Regenerative Medicine: Reality, Hype, and Future,” authors Anthony Atala and Gabor Forgacs explore some necessary topics within 3D printing and bioprinting. The technology has brought forth incredible innovation capable of transforming manufacturing, design mechanisms, and offering never dreamed of self-sustainability that could be even more useful in the future

Read More


Graphene 3D printing

As discoveries around graphene applications abound, many are wondering if it can be scaled to 3D. This could have revolutionary effects, but it begs the question, have scientists been successful in graphene 3D printing? Find out! GRAPHENE 3D PRINTING Is It Possible? So, is it possible to 3D print graphene? The short answers is, not

Read More


US Researchers Continue to Improve 3D Printed Prosthetics for Children

US researchers from the University of Central Florida and Oregon Health and Science University have come together to review the history not only of prosthetics overall in the medical field but also to further inspect the transformation allowed by 3D printing. Contending that there are still many problems to be solved in prosthetics, the authors further explore children’s physical

Read More


Artificial Intelligence in Health Care Will the Value Match the Hype?

Source: JAMA Artificial intelligence (AI) and its many related applications (ie, big data, deep analytics, machine learning) have entered medicine’s “magic bullet” phase. Desperate for a solution for the never-ending challenges of cost, quality, equity, and access, a steady stream of books, articles, and corporate pronouncements makes it seem like health care is on the

Read More